iShares S&P MidCap 400 Growth Index Fund (NYSEARCA:IJK) is in the Danger Zone this week because its holdings are much worse than the other mid-cap growth "index" ETFs.
Do Not Trust ETF Labels - Even "Index" Labels
Many ETFs are labeled "index" ETFs. Naturally, many investors assume that having "index" in the ETF's name means all the holdings are the same or the provider cannot influence the nature of the holdings, but that is not true.
For example, of the three "index" ETFs in the mid-cap growth style, two get a Neutral rating while one gets a Dangerous rating. How is that possible if they are supposed to hold the same stocks? The answer is that they do not hold the same stocks.
There is no overlap in the top 5 holdings among these three ETFs. Their portfolios are not close to being the same. And there is a meaningful difference in the quality of holdings.
iShares S&P MidCap 400 Growth Index Fund gets 2-stars or a Dangerous rating because it has dangerous-rated holdings.
The "index" label, for mid-cap growth ETFs, is misleading as it does not mean that these ETFs have the same portfolio of holdings.
The point is that investors cannot trust the "index" label to mean that all the ETFs or mutual funds with that label hold a standard portfolio of stocks.
Three of IJK's top five holdings get my Dangerous rating or worse. Equinix Inc (NASDAQ:EQIX) gets my Very Dangerous rating because the firm's reported earnings are misleading compared to its economic earnings and the stock's valuation is very expensive.
IJK's holdings tend to be in stocks that I find very expensive and for which the risk/reward is poor. For example, both Vertex Pharmaceuticals (NASDAQ:VRTX) and Regeneron Pharmaceuticals (NASDAQ:REGN) have valuations that imply unprecedented improvement in revenues and profits according to my discounted cash flow model. The expectations for future cash flows already reflected in those stocks present more downside risk than upside potential.
I would not recommend investors buy those stocks on a standalone basis or as part of an ETF or any portfolio. Diversification should be executed among good stocks. it is not a reason to own bad stocks.
The Danger Within
Buying an ETF without analyzing its holdings is like buying a stock without analyzing its business and finances. As Barron's says, investors should know the Danger Within. Put another way, research on ETF holdings is necessary due diligence because an ETF's performance is only as good as its holdings' performance.
PERFORMANCE OF ETF's HOLDINGs = PERFORMANCE OF ETF
Note that no ETFs with a dangerous portfolio management rating earn an overall rating better than two stars. These scores are consistent with my belief that the quality of an ETF is more about its holdings than its costs. If the ETF's holdings are dangerous, then the overall rating cannot be better than dangerous because one cannot expect the performance of the ETF to be any better than the performance of its holdings.
How To Avoid ETFs with the Worst Holdings
Assessing an ETF's holdings is important because an ETF's performance is determined more by its holdings than its costs. Figure 1 shows the ETFs within each style with the worst holdings or portfolio management ratings. The styles are listed in descending order by overall rating as detailed in my 4Q Style Rankings report.
Figure 1: Style ETFs With Worst Holdings
Sources: New Constructs, LLC and company filings
iShares' ETFs appear more often than any other provider in Figure 1, which means they offer the most ETFs with the worst holdings. iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH) has the worst holdings of all mid cap blend ETFs. iShares Russell 1000 Growth (NYSEARCA:IWF), iShares S&P 500 Value Index Fund (NYSEARCA:IVE), iShares Russell 3000 Growth Index Fund (IWZ), iShares S&P MidCap 400 Growth Index Fund, iShares Russell 2000 Growth (NYSEARCA:IWO), iShares Russell Midcap Value Index (NYSEARCA:IWS), iShares Russell 2000 Index Fund (NYSEARCA:IWM), iShares Russell 2000 Value Index Fund (NYSEARCA:IWN) have the worst holdings of all ETFs in their styles.
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.